BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 14519683)

  • 1. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
    Winokur ST; Chen YW; Masny PS; Martin JH; Ehmsen JT; Tapscott SJ; van der Maarel SM; Hayashi Y; Flanigan KM
    Hum Mol Genet; 2003 Nov; 12(22):2895-907. PubMed ID: 14519683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients.
    Rijkers T; Deidda G; van Koningsbruggen S; van Geel M; Lemmers RJ; van Deutekom JC; Figlewicz D; Hewitt JE; Padberg GW; Frants RR; van der Maarel SM
    J Med Genet; 2004 Nov; 41(11):826-36. PubMed ID: 15520407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
    Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
    Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease?
    Masny PS; Bengtsson U; Chung SA; Martin JH; van Engelen B; van der Maarel SM; Winokur ST
    Hum Mol Genet; 2004 Sep; 13(17):1857-71. PubMed ID: 15238509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy].
    Desnuelle C; Sacconi S; Marolleau JP; Larghero J; Vilquin JT
    Bull Acad Natl Med; 2005 Apr; 189(4):697-713; discussion 713-4. PubMed ID: 16245686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues.
    Tsien F; Sun B; Hopkins NE; Vedanarayanan V; Figlewicz D; Winokur S; Ehrlich M
    Mol Genet Metab; 2001 Nov; 74(3):322-31. PubMed ID: 11708861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression during normal and FSHD myogenesis.
    Tsumagari K; Chang SC; Lacey M; Baribault C; Chittur SV; Sowden J; Tawil R; Crawford GE; Ehrlich M
    BMC Med Genomics; 2011 Sep; 4():67. PubMed ID: 21951698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.
    Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR
    Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary genomic remodelling of the human 4q subtelomere (4q35.2).
    Bodega B; Cardone MF; Müller S; Neusser M; Orzan F; Rossi E; Battaglioli E; Marozzi A; Riva P; Rocchi M; Meneveri R; Ginelli E
    BMC Evol Biol; 2007 Mar; 7():39. PubMed ID: 17359533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns.
    Cheli S; François S; Bodega B; Ferrari F; Tenedini E; Roncaglia E; Ferrari S; Ginelli E; Meneveri R
    PLoS One; 2011; 6(6):e20966. PubMed ID: 21695143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genes encoding for D4Z4 binding proteins HMGB2, YY1, NCL, and MYOD1 are excluded as candidate genes for FSHD1B.
    Bastress KL; Stajich JM; Speer MC; Gilbert JR
    Neuromuscul Disord; 2005 Apr; 15(4):316-20. PubMed ID: 15792872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation.
    Bodega B; Ramirez GD; Grasser F; Cheli S; Brunelli S; Mora M; Meneveri R; Marozzi A; Mueller S; Battaglioli E; Ginelli E
    BMC Biol; 2009 Jul; 7():41. PubMed ID: 19607661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-411 is up-regulated in FSHD myoblasts and suppresses myogenic factors.
    Harafuji N; Schneiderat P; Walter MC; Chen YW
    Orphanet J Rare Dis; 2013 Apr; 8():55. PubMed ID: 23561550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
    Upadhyaya M; Cooper DN
    Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy.
    Broucqsault N; Morere J; Gaillard MC; Dumonceaux J; Torrents J; Salort-Campana E; Maues De Paula A; Bartoli M; Fernandez C; Chesnais AL; Ferreboeuf M; Sarda L; Dufour H; Desnuelle C; Attarian S; Levy N; Nguyen K; Magdinier F; Roche S
    Hum Mol Genet; 2013 Oct; 22(20):4206-14. PubMed ID: 23777630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
    Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
    Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies.
    Morosetti R; Mirabella M; Gliubizzi C; Broccolini A; Sancricca C; Pescatori M; Gidaro T; Tasca G; Frusciante R; Tonali PA; Cossu G; Ricci E
    Stem Cells; 2007 Dec; 25(12):3173-82. PubMed ID: 17761758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of expression of muscle specific isoforms of the fragile X related protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy patients.
    Davidovic L; Sacconi S; Bechara EG; Delplace S; Allegra M; Desnuelle C; Bardoni B
    J Med Genet; 2008 Oct; 45(10):679-85. PubMed ID: 18628314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FSHD region on human chromosome 4q35 contains potential coding regions among pseudogenes and a high density of repeat elements.
    van Geel M; Heather LJ; Lyle R; Hewitt JE; Frants RR; de Jong PJ
    Genomics; 1999 Oct; 61(1):55-65. PubMed ID: 10512680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.